Literature DB >> 23293064

Neutrophils regulate tissue Neutrophilia in inflammation via the oxidant-modified lipid lysophosphatidylserine.

S Courtney Frasch1, Ruby F Fernandez-Boyanapalli, Karin A Zemski Berry, Robert C Murphy, Christina C Leslie, Jerry A Nick, Peter M Henson, Donna L Bratton.   

Abstract

Resolution of neutrophilia characteristic of acute inflammation requires cessation of neutrophil recruitment and removal of tissue neutrophils. Based on in vitro studies, a role in these events was hypothesized for oxidant-generated lysophosphatidylserine (lyso-PS) on recruited neutrophils signaling via the G2A receptor on macrophages. Peritoneal exudate neutrophils harvested from wild type (WT) mice had 5-fold more lyso-PS (lyso-PS(high)) than those of gp91(phox)(-/-) (lyso-PS(low)) mice. Ex vivo engulfment of lyso-PS(high) neutrophils (95% viable) by WT peritoneal macrophages was quantitatively similar to UV-irradiated apoptotic blood neutrophils, although the signaling pathway for the former was uniquely dependent on macrophage G2A. In contrast, lyso-PS(low) neutrophils were poorly engulfed unless presented with exogenous lyso-PS. Enhanced clearance of lyso-PS(high) neutrophils was also seen in vivo following their adoptive transfer into inflamed peritonea of WT but not G2A(-/-) mice, further supporting a requirement for signaling via G2A. To investigate downstream effects of lyso-PS/G2A signaling, antibody blockade of G2A in WT mice reduced macrophage CD206 expression and efferocytosis during peritonitis. Conversely, adoptive transfer of lyso-PS(high) neutrophils early in inflammation in gp91(phox)(-/-) mice led to accelerated development of efferocytic(high) and CD206(high) macrophages. This macrophage reprogramming was associated with suppressed production of pro-inflammatory mediators and reduced neutrophilia. These effects were not seen if G2A was blocked or lyso-PS(low) neutrophils were transferred. Taken together, the results demonstrate that oxidant-generated lyso-PS made by viable tissue neutrophils is an endogenous anti-inflammatory mediator working in vivo to orchestrate the "early" and rapid clearance of recruited neutrophils as well as the reprogramming of "resolving" macrophages.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23293064      PMCID: PMC3576064          DOI: 10.1074/jbc.M112.438507

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

Review 1.  Clearance of apoptotic cells by phagocytes.

Authors:  L-P Erwig; P M Henson
Journal:  Cell Death Differ       Date:  2007-06-15       Impact factor: 15.828

Review 2.  Alternative activation of macrophages: an immunologic functional perspective.

Authors:  Fernando O Martinez; Laura Helming; Siamon Gordon
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

3.  Nonresolving inflammation in gp91phox-/- mice, a model of human chronic granulomatous disease, has lower adenosine and cyclic adenosine 5'-monophosphate.

Authors:  Ravindra Rajakariar; Justine Newson; Edwin K Jackson; Precilla Sawmynaden; Andrew Smith; Farooq Rahman; Muhammad M Yaqoob; Derek W Gilroy
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

4.  Impaired apoptotic cell clearance in CGD due to altered macrophage programming is reversed by phosphatidylserine-dependent production of IL-4.

Authors:  Ruby F Fernandez-Boyanapalli; S Courtney Frasch; Kathleen McPhillips; R William Vandivier; Brian L Harry; David W H Riches; Peter M Henson; Donna L Bratton
Journal:  Blood       Date:  2008-10-24       Impact factor: 22.113

5.  Lysophospholipids of different classes mobilize neutrophil secretory vesicles and induce redundant signaling through G2A.

Authors:  S Courtney Frasch; Karin Zemski-Berry; Robert C Murphy; Niels Borregaard; Peter M Henson; Donna L Bratton
Journal:  J Immunol       Date:  2007-05-15       Impact factor: 5.422

6.  NADPH oxidase-dependent generation of lysophosphatidylserine enhances clearance of activated and dying neutrophils via G2A.

Authors:  S Courtney Frasch; Karin Zemski Berry; Ruby Fernandez-Boyanapalli; Hyun-Sun Jin; Christina Leslie; Peter M Henson; Robert C Murphy; Donna L Bratton
Journal:  J Biol Chem       Date:  2008-09-29       Impact factor: 5.157

Review 7.  G2A and LPC: regulatory functions in immunity.

Authors:  Janusz H Kabarowski
Journal:  Prostaglandins Other Lipid Mediat       Date:  2009-04-19       Impact factor: 3.072

8.  Involvement of a functional NADPH oxidase in neutrophils and macrophages during programmed cell clearance: implications for chronic granulomatous disease.

Authors:  Duangmanee Sanmun; Erika Witasp; Siriporn Jitkaew; Yulia Y Tyurina; Valerian E Kagan; Anders Ahlin; Jan Palmblad; Bengt Fadeel
Journal:  Am J Physiol Cell Physiol       Date:  2009-07-01       Impact factor: 4.249

9.  Efferocytosis impairs pulmonary macrophage and lung antibacterial function via PGE2/EP2 signaling.

Authors:  Alexandra I Medeiros; Carlos H Serezani; Sang Pyo Lee; Marc Peters-Golden
Journal:  J Exp Med       Date:  2009-01-05       Impact factor: 14.307

10.  Resolution-phase macrophages possess a unique inflammatory phenotype that is controlled by cAMP.

Authors:  Jonas Bystrom; Ian Evans; Justine Newson; Melanie Stables; Iqbal Toor; Nico van Rooijen; Mark Crawford; Paul Colville-Nash; Stuart Farrow; Derek W Gilroy
Journal:  Blood       Date:  2008-09-08       Impact factor: 22.113

View more
  25 in total

1.  Phospholipids: a neuroinflammation emerging target.

Authors:  Hee-Yong Kim
Journal:  Nat Chem Biol       Date:  2015-02       Impact factor: 15.040

2.  G2A Signaling Dampens Colitic Inflammation via Production of IFN-γ.

Authors:  S Courtney Frasch; Eóin N McNamee; Douglas Kominsky; Paul Jedlicka; Claudia Jakubzick; Karin Zemski Berry; Matthias Mack; Glenn T Furuta; James J Lee; Peter M Henson; Sean P Colgan; Donna L Bratton
Journal:  J Immunol       Date:  2016-07-08       Impact factor: 5.422

3.  Subcutaneous administration of Lyso-phosphatidylserine nanoparticles induces immunological tolerance towards Factor VIII in a Hemophilia A mouse model.

Authors:  Fiona Y Glassman; Sathy V Balu-Iyer
Journal:  Int J Pharm       Date:  2018-07-05       Impact factor: 5.875

Review 4.  Apoptotic cell clearance: basic biology and therapeutic potential.

Authors:  Ivan K H Poon; Christopher D Lucas; Adriano G Rossi; Kodi S Ravichandran
Journal:  Nat Rev Immunol       Date:  2014-01-31       Impact factor: 53.106

Review 5.  Myeloid Cell Turnover and Clearance.

Authors:  William J Janssen; Donna L Bratton; Claudia V Jakubzick; Peter M Henson
Journal:  Microbiol Spectr       Date:  2016-11

6.  Pioglitazone restores phagocyte mitochondrial oxidants and bactericidal capacity in chronic granulomatous disease.

Authors:  Ruby F Fernandez-Boyanapalli; S Courtney Frasch; Stacey M Thomas; Kenneth C Malcolm; Michael Nicks; Ronald J Harbeck; Claudia V Jakubzick; Raphael Nemenoff; Peter M Henson; Steven M Holland; Donna L Bratton
Journal:  J Allergy Clin Immunol       Date:  2014-12-10       Impact factor: 10.793

7.  Oxidatively modified phosphatidylserines on the surface of apoptotic cells are essential phagocytic 'eat-me' signals: cleavage and inhibition of phagocytosis by Lp-PLA2.

Authors:  V A Tyurin; K Balasubramanian; D Winnica; Y Y Tyurina; A S Vikulina; R R He; A A Kapralov; C H Macphee; V E Kagan
Journal:  Cell Death Differ       Date:  2014-01-24       Impact factor: 15.828

8.  Polysaccharide-rich fraction of Termitomyces eurhizus accelerate healing of indomethacin induced gastric ulcer in mice.

Authors:  Ananya Chatterjee; Somanjana Khatua; Sirshendu Chatterjee; Shatavisa Mukherjee; Atashi Mukherjee; Soumitra Paloi; Krishnendu Acharya; Sandip K Bandyopadhyay
Journal:  Glycoconj J       Date:  2013-05-30       Impact factor: 2.916

Review 9.  The Lysophosphatidylserines-An Emerging Class of Signalling Lysophospholipids.

Authors:  Karthik Shanbhag; Amol Mhetre; Neha Khandelwal; Siddhesh S Kamat
Journal:  J Membr Biol       Date:  2020-08-07       Impact factor: 1.843

Review 10.  Novel lysophosphoplipid receptors: their structure and function.

Authors:  Kumiko Makide; Akiharu Uwamizu; Yuji Shinjo; Jun Ishiguro; Michiyo Okutani; Asuka Inoue; Junken Aoki
Journal:  J Lipid Res       Date:  2014-06-02       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.